Lack of association between the genetic variations in the C-reactive protein gene and the risk of psoriasis among the Taiwanese

详细信息    查看全文

• 作者：Ya-Ching Chang (1)
  Wei-Ming Wu (2)
  Lung-An Hsu (3) hsula@adm.cgmh.org.tw
• 关键词：C ; reactive protein &#8211 ; Polymorphism &#8211 ; Psoriasis
• 刊名：Molecular Biology Reports
• 出版年：2012
• 出版时间：April 2012
• 年：2012
• 卷：39
• 期：4
• 页码：4111-4117
• 全文大小：189.1 KB
• 参考文献：1. Chang EY, Hammerberg C, Fisher G et al (1992) T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis. Arch Dermatol 128:1479–1485
  2. Bata-Csorgo Z, Hammerberg C, Voorhees JJ et al (1995) Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J Clin Invest 95:317–327
  3. Henseler T (1997) The genetics of psoriasis. J Am Acad Dermatol 37:S1–S11
  4. Torzewski J, Torzewski M, Bowyer DE et al (1998) C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 18:1386–1392
  5. Verma S, Li SH, Badiwala MV et al (2002) Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 105:1890–1896
  6. Ridker PM, Cushman M, Stampfer MJ et al (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973–979
  7. Ridker PM, Rifai N, Rose L et al (2002) Comparison of C-reactive protein and low density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557–1565
  8. Koenig W, Sund M, Frohlich M et al (1999) C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99:237–242
  9. Danesh J, Wheeler JG, Hirschfield GM et al (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397
  10. Pai JK, Pischon T, Ma J et al (2004) Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351:2599–2610
  11. Rocha-Pereira P, Santos-Silva A, Rebelo I et al (2004) The inflammatory response in mild and in severe psoriasis. Br J Dermatol 150:917–928
  12. Chodorowska G, Wojnowska D, Juszkiewicz-Borowiec M (2004) C-reactive protein and alpha 2-macroglobulin plasma activity in medium-severe and severe psoriasis. J Eur Acad Dermatol Venereol 18:180–183
  13. Strober B, Teller C, Yamauchi P et al (2008) Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis. Br J Dermatol 159:322–330
  14. Biljan D, Situm M, Kostović K et al (2009) Acute phase proteins in psoriasis. Coll Antropol 33:83–86
  15. Sergeant A, Makrygeorgou A, Chan WC et al (2008) C-reactive protein in psoriasis. Br J Dermatol 158:417–419
  16. Coimbra S, Oliveira H, Reis F et al (2010) C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol 24:789–796
  17. Coimbra S, Oliveira H, Reis F et al (2010) Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. J Eur Acad Dermatol Venereol 24:1386–1394
  18. Coimbra S, Oliveira H, Reis F, Belo L et al (2009) Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease. J Dermatol Sci 55:202–204
  19. Ledue TB, Rifai N (2003) Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. Clin Chem 49:1258–1271
  20. Pankow JS, Folsom AR, Cushman M et al (2001) Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 154:681–689
  21. Retterstol L, Eikvar L, Berg K (2003) A twin study of C-reactive protein compared to other risk factors for coronary heart disease. Atherosclerosis 169:279–282
  22. MacGregor AJ, Gallimore JR, Spector TD et al (2004) Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: a comparison of monozygotic and dizygotic twins. Clin Chem 50:130–134
  23. Hage FG, Szalai AJ (2007) C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol 50:1115–1122
  24. Chang YC, Wu WM, Chen CH et al (2007) Association between the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and risk for psoriasis in a Chinese population in Taiwan. Br J Dermatol 156:642–645
  25. Teng MS, Hsu LA, Wu S et al (2009) Association between C-reactive protein gene haplotypes and C-reactive protein levels in Taiwanese: interaction with obesity. Atherosclerosis 204:e64–e69
  26. Sol茅 X, Guin贸 E, Valls J et al (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22:1928–1929
  27. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978–979
  28. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866–873
  29. Yasojima K, Schwab C, McGeer EG et al (2001) Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 158:1039–1051
  30. Jabs WJ, L枚gering BA, Gerke P et al (2003) The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol 33:152–161
  31. Ouchi N, Kihara S, Funahashi T et al (2003) Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107:671–674
  32. Ballou SP, Lozanski G (1992) Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4:361–368
  33. Bharadwaj D, Stein MP, Volzer M et al (1999) The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med 190:585–590
  34. Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165–2168
  35. Zwaka TP, Hombach V, Torzewski J (2001) C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 103:1194–1197
  36. Zacho J, Tybjaerg-Hansen A, Jensen JS et al (2008) Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 359:1897–1908
  37. Elliott P, Chambers JC, Zhang W et al (2009) Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302:37–48
  38. Szalai AJ, Wu J, Lange EM et al (2005) Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med 83:440–447
  39. Chen J, Zhao J, Huang J et al (2005) −717A>G polymorphism of human C-reactive protein gene associated with coronary heart disease in ethnic Han Chinese: the Beijing atherosclerosis study. J Mol Med 83:72–78
• 作者单位：1. Department of Dermatology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taipei, Taiwan, ROC2. Department of Dermatology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan, ROC3. First Cardiovascular Division, Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, No. 199, Tung-Hwa North Road, Taipei, Taiwan, ROC
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Life Sciences
  Animal Anatomy, Morphology and Histology
  Animal Biochemistry
  
• 出版者：Springer Netherlands
• ISSN：1573-4978

文摘

Psoriasis is a chronic disease characterized by inflammation of the skin. The level of C-reactive protein (CRP), an inflammatory marker that correlates well with the severity of psoriasis, is a heritable trait. This study aimed to assess the role of variations in the CRP gene in patients with psoriasis among the Chinese-Taiwanese. In total, 305 patients with psoriasis and 615 control subjects were analyzed for the presence of the CRP polymorphisms rs2794521, rs3091244, and rs1800947 by polymerase chain reaction. The analysis revealed that neither polymorphism was found to be associated with psoriasis. No significant difference was observed in the genotype and allele distribution for any of the individual CRP polymorphisms between the cases and the controls. The overall haplotype frequency profiles derived from the three polymorphisms did not differ significantly between the cases and the controls. Our results suggest that these three CRP gene polymorphisms may not contribute to the genetic background of psoriasis in Chinese-Taiwanese.